Prokaryotics : Prokaryotics gets $2.3 mn SBIR grant from NIH to support its immune potentiation programme, advance two additional antibiotics

Prokaryotics, Inc., a privately─held biopharmaceutical company engaged in the discovery and development of novel anti─infective drugs, announced that it has been awarded its third Small Business Innovation